Bennani S, Aboutaieb R, el Mrini M, Benjelloun S
Service d'Urologie, CHU Averroès, Casablanca, Maroc.
Ann Urol (Paris). 1994;28(5):243-9.
Despite the efficacy of new tuberculostatic agents, urogenital tuberculosis still constitutes a threat to renal function due to fibrosis secondary to healing of the lesions. The authors studied the place of corticosteroids, and endoscopic and percutaneous procedures in the treatment of 86 cases of urogenital tuberculosis. Corticosteroids were coprescribed with tuberculostatic agents in 20 patients: 16 ureteral strictures were treated with 8 success and 8 failures, 8 contracted bladders were treated with 5 success and 3 failures. Three cases of retraction of the renal pelvis were treated by corticosteroids with 2 successes and one failure. Ureteral stricture was treated by retrograde ureteral stenting in 5 cases and by percutaneous antegrade ureteral stenting in one case with 4 successes and 2 failures. This study more clearly defines the indications for corticosteroids and endoscopic treatment with particular reference to new endoscopic surgery techniques.
尽管新型抗结核药物有疗效，但由于病变愈合继发纤维化，泌尿生殖系统结核仍对肾功能构成威胁。作者研究了皮质类固醇、内镜及经皮手术在86例泌尿生殖系统结核治疗中的作用。20例患者在使用抗结核药物的同时加用了皮质类固醇：16例输尿管狭窄患者接受治疗，8例成功，8例失败；8例膀胱挛缩患者接受治疗，5例成功，3例失败。3例肾盂退缩患者接受皮质类固醇治疗，2例成功，1例失败。5例输尿管狭窄患者接受逆行输尿管支架置入术治疗，1例接受经皮顺行输尿管支架置入术治疗，4例成功，2例失败。本研究更明确地界定了皮质类固醇及内镜治疗的适应证，尤其涉及新型内镜手术技术。
